4 Lantéri-Minet M, Massiou H, Romatet S, et al. An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study)[J]. Headache, 2011, 51(4): 590-601.
6 Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force[J]. Eur J Neurol. 2009, 16(9): 968-981.
[7]
7 Tfelt-Hansen PC. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society[J]. Neurology, 2013, 80(9): 869-870.
[8]
8 Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelines[J]. Neuropsychiatr Dis Treat, 2013, 9: 709-720.
[9]
9 Tfelt-Hansen PC, Hougaard A. Migraine: new US guidelines for preventive treatment of migraine[J]. Nat Rev Neurol, 2012, 8(8): 419-421.
[10]
10 Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies[J]. Headache, 2015, 55(1): 3-20.
